Binding of GTPγ[35S] is regulated by GDP and receptor activation. Studies with the nociceptin/orphanin FQ receptor

作者: John McDonald , David G Lambert

DOI: 10.1111/J.1476-5381.2009.00621.X

关键词: GDP bindingGuanosine 5'-O-(3-Thiotriphosphate)ReceptorGuanosineNociceptin receptorNOPPartial agonistStereochemistryGuanosine diphosphateChemistry

摘要: Background and purpose:  We have examined the effects of ligand efficacy receptor density on binding guanosine 5′-[γ-thio]triphosphate (GTPγS) GDP to nociceptin/orphanin FQ (N/OFQ) peptide (NOP)-coupled G-proteins. Experimental approach:  In GTPγ[35S] experiments, using stable (CHOhNOP) inducible (CHOINDhNOP) recombinant human rat NOP we measured: (i) ligand-specific requirements; (ii) guanine nucleotide affinity/capacity; (iii) effect GTPγS association kinetics. Key results:  competition curves were shallow modelled by high- low-affinity components that relatively consistent between cell types tissue preparations. presence 1 µM N/OFQ a high-affinity site was also present, but fraction total reduced. an efficacy-dependent manner, partial agonists [F/G]N/OFQ(1-13)NH2 ([Phe1ψ(CH2-NH)Gly2]-nociceptin(1-13)NH2) naloxone benzoylhydrazone both reduced sites for (relative basal). While pIC50 did not decrease in N/OFQ, produced significant reduction site. Agonist-mediated affinity efficacy-dependent. displayed three affinities: high, conserved absence ligand; intermediate, present as low under basal conditions; (efficacy-dependent), during activation representing majority binding. Conclusions implications:  The regulated caused increased through affinity.

参考文章(21)
Stefan R. Nahorski, John R. Traynor, Modulation by mu-opioid agonists of guanosine-5'-O-(3-[35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells Molecular Pharmacology. ,vol. 47, pp. 848- 854 ,(1995)
K M Ferguson, T Higashijima, M D Smigel, A G Gilman, The influence of bound GDP on the kinetics of guanine nucleotide binding to G proteins. Journal of Biological Chemistry. ,vol. 261, pp. 7393- 7399 ,(1986) , 10.1016/S0021-9258(17)38404-1
A. Lewis Farr, Oliver H. Lowry, Rose J. Randall, Nira J. Rosebrough, Protein Measurement with the Folin Phenol Reagent Journal of Biological Chemistry. ,vol. 193, pp. 265- 275 ,(1951)
Hartmut Berger, Raffaella Bigoni, Erika Albrecht, Regina M Richter, Eberhard Krause, Michael Bienert, Girolamo Calo’, The nociceptin/orphanin FQ receptor ligand acetyl-RYYRIK-amide exhibits antagonistic and agonistic properties Peptides. ,vol. 21, pp. 1131- 1139 ,(2000) , 10.1016/S0196-9781(00)00251-5
R Bigoni, G Calò, A Rizzi, H Okawa, D Regoli, D Smart, D G Lambert, Effects of naloxone benzoylhydrazone on native and recombinant nociceptin/orphanin FQ receptors Canadian Journal of Physiology and Pharmacology. ,vol. 80, pp. 407- 412 ,(2002) , 10.1139/Y02-040
David G. Lambert, The nociceptin/orphanin FQ receptor: a target with broad therapeutic potential Nature Reviews Drug Discovery. ,vol. 7, pp. 694- 710 ,(2008) , 10.1038/NRD2572
Girolamo Calo', Remo Guerrini, Anna Rizzi, Severo Salvadori, Domenico Regoli, Pharmacology of nociceptin and its receptor: a novel therapeutic target British Journal of Pharmacology. ,vol. 129, pp. 1261- 1283 ,(2000) , 10.1038/SJ.BJP.0703219
J McDonald, T A Barnes, H Okawa, J Williams, G Calo', D J Rowbotham, D G Lambert, Partial agonist behaviour depends upon the level of nociceptin/orphanin FQ receptor expression: studies using the ecdysone‐inducible mammalian expression system British Journal of Pharmacology. ,vol. 140, pp. 61- 70 ,(2003) , 10.1038/SJ.BJP.0705401
Terry Kenakin, Ligand-selective receptor conformations revisited: the promise and the problem Trends in Pharmacological Sciences. ,vol. 24, pp. 346- 354 ,(2003) , 10.1016/S0165-6147(03)00167-6